Researcher.Life Logo

Allergy and Asthma Proceedings : Impact Factor & More

eISSN: 1539-6304pISSN: 1088-5412

Key Metrics

CiteScore
4.9
Impact Factor
< 5
SJR
Q3Immunology and Allergy
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Allergy and Asthma Proceedings

Allergy and Asthma Proceedings Journal Specifications

Overview
Publisher OCEAN SIDE PUBLICATIONS INC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Allergy and Asthma Proceedings ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Allergy and Asthma Proceedings

Cow's milk protein allergy: A risk factor for infections in infants?
  • 1 Mar 2026
  • Allergy and asthma proceedings
What to do when your adult patient with severe asthma does not respond to a biologic.
  • 1 Mar 2026
  • Allergy and asthma proceedings
Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations.
  • 1 Mar 2026
  • Allergy and asthma proceedings
Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze.
  • 1 Mar 2026
  • Allergy and asthma proceedings
From molecular pathways to meaningful patient management: Navigating complexity in allergy and immunology.
  • 1 Mar 2026
  • Allergy and asthma proceedings
Comprehensive assessment of allergic manifestations including drug hypersensitivity in adult patients with inborn errors of immunity.
  • 1 Mar 2026
  • Allergy and asthma proceedings
Cow's milk protein allergy: A risk factor for infections in infants?
  • 1 Mar 2026
  • Allergy and asthma proceedings
What to do when your adult patient with severe asthma does not respond to a biologic.
  • 1 Mar 2026
  • Allergy and asthma proceedings
Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations.
  • 1 Mar 2026
  • Allergy and asthma proceedings
Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze.
  • 1 Mar 2026
  • Allergy and asthma proceedings
From molecular pathways to meaningful patient management: Navigating complexity in allergy and immunology.
  • 1 Mar 2026
  • Allergy and asthma proceedings
Comprehensive assessment of allergic manifestations including drug hypersensitivity in adult patients with inborn errors of immunity.
  • 1 Mar 2026
  • Allergy and asthma proceedings

FAQs on Allergy and Asthma Proceedings